Kiniksa Pharmaceuticals International, plc (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

78.20

-2.72 (-3.36%)

At close: Jul 30, 2026, 4:00 PM EDT

78.31

+0.11 (0.14%)

After-hours: Jul 30, 2026, 7:59 PM EDT

KNSA Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	840.85	677.56	423.24	270.26	220.18	38.54
Revenue Growth	58.85%	60.09%	56.61%	22.75%	471.24%	-
Cost of Revenue	85.57	77.67	60.91	33.41	22.9	9.1
Gross Profit	755.28	599.89	362.33	236.85	197.29	29.44
Selling, General & Admin	230.9	196.27	168.01	129.43	97.95	85.95
Research & Development	127.15	96.85	111.62	76.1	65.49	99.3
Other Operating Expenses	296.98	229.55	128.31	56.52	24.07	0.84
Total Operating Expenses	655.03	522.67	407.95	262.05	187.51	186.08
Operating Income	100.25	77.22	-45.62	-25.2	9.77	-156.64
Total Non-Operating Income (Expense)	14	11.65	9.46	8.54	1.25	0.1
Pretax Income	114.25	88.87	-36.15	-16.65	11.03	-156.54
Provision for Income Taxes	24.52	29.86	7.04	-30.74	-172.34	1.39
Net Income	80.66	59.01	-43.19	14.08	183.36	-157.92
Net Income to Common	80.66	59.01	-43.19	14.08	183.36	-157.92
Net Income Growth	1583.88%	-	-	-92.32%	-	-
Shares Outstanding (Basic)	76	74	71	70	69	69
Shares Outstanding (Diluted)	82	79	71	72	70	69
Shares Change	9.82%	10.58%	-0.69%	2.13%	2.69%	10.89%
EPS (Basic)	0.69	0.80	-0.60	0.20	2.64	-2.30
EPS (Diluted)	0.63	0.75	-0.60	0.20	2.60	-2.30
EPS Growth	1475.00%	-	-	-92.31%	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	182.84	136.42	25.41	13.17	5.7	-126.71
Free Cash Flow Growth	174.98%	436.82%	92.94%	130.99%	-	-
Free Cash Flow Per Share	2.23	1.73	0.36	0.18	0.08	-1.85
Gross Margin	89.82%	88.54%	85.61%	87.64%	89.60%	76.39%
Operating Margin	11.92%	11.40%	-10.78%	-9.32%	4.44%	-406.38%
Profit Margin	9.59%	8.71%	-10.21%	5.21%	83.28%	-409.72%
FCF Margin	21.74%	20.13%	6.00%	4.87%	2.59%	-328.75%
EBITDA	102.04	78.78	-43.92	-22.86	12.18	-154.28
EBITDA Margin	12.14%	11.63%	-10.38%	-8.46%	5.53%	-400.27%
EBIT	100.25	77.22	-45.62	-25.2	9.77	-156.64
EBIT Margin	11.92%	11.40%	-10.78%	-9.32%	4.44%	-406.38%
Effective Tax Rate	21.46%	33.60%	-19.48%	184.58%	-1563.01%	-0.88%

SEC Filings: 10-K · 10-Q